<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Brai, Emanuele</dc:creator>
  <dc:creator>Raio, Noemi Alina</dc:creator>
  <dc:creator>Alberi, Lavinia</dc:creator>
  <dc:date>2016-07-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: Notch1 signaling is a cellular cascade with a fundamental role from brain  development to adult brain function. Reduction in Notch1 affects synaptic plasticity,  memory and olfaction. On the other hand, Notch1 overactivation after brain injury is  detrimental for neuronal survival. Some familial Alzheimer’s disease (FAD) mutations in  Presenilins can affect Notch1 processing/activation. Others report that Notch1 is  overexpressed in sporadic Alzheimer’s disease (AD). These works indicate that  imbalances in Notch1 may be implicated in AD pathophysiology. In this study, we  addressed whether Notch1 alteration can be considered a hallmark of AD.Results:  Immunohistochemical analysis of Notch1 on cortical and hippocampal tissue from  post-mortem patients indicates an accumulation of Notch1 in plaque-like structures in  the brain parenchyma of subjects with sporadic AD. Further analysis shows that  displaced Notch1 is associated with fibrillary tangles/plaques. Biochemical validation  confirms an accumulation of Notch1 in cytosolic brain fractions. This increase in  protein is not accompanied with a raise in the Notch1 targets Hes1 and Hey1.  Examination of the cerebrospinal fluid (CSF) indicates that the full length and  truncations of the Notch1 protein are reduced in AD patients hinting at an accumulation  in the brain parenchyma.Conclusions: Our research indicates that Notch1 is  significantly displaced and accumulated in fibrillary structures in the susceptible  hippocampal and cortical regions of sporadic AD patients. The dominant deposition of  Notch1 in the brain parenchyma and its general signal reduction in neurons is  consistent in all the AD patients analyzed and suggests that Notch1 may potentially be  considered a novel hallmark of AD.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/304948</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304948/files/alb_nhf.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304948/files/alb_nhf_err.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/s40478-016-0327-2</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Acta Neuropathologica Communications. - 2016, vol. 4, p. 64</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Notch1</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Sporadic Alzheimer’s disease</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Amyloid plaques</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Tau</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Cerebrospinal fluid</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns6="xml" ns6:lang="en">Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
